Each full guideline is presented below, in alphabetical order, with a short non-technical summary alongside the main guideline. The non-technical summary is less detailed than the full guideline and if you are reading this because it is relevant to your own healthcare, please do discuss any concerns or questions with your healthcare professionals.

* Guidelines currently being revised

Antiretroviral treatment

• Treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update) *

• View non-technical summary

  There are four non-technical summaries:
  
  - ART guidelines for HIV
  
  - Changing ART
  
  - ART & other health issues
  
  - ART - What's new
  

COVID-19

• Management of adults with HIV on antiretroviral treatment (ART) during the coronavirus pandemic 2020

• Non-technical summary in development

Hepatitis

• Management of hepatitis viruses in adults infected with HIV 2013 (updated September 2014) *

  Please note: This guideline is currently being revised.
  In the interim, please refer to https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf​

• Non-technical summary in development

HIV-2 management

• Antiretroviral treatment of HIV-2 positive individuals 2010 *

  Please note: This guideline is obsolete and currently in the process of being updated.
  In the interim, please refer to https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf

• Non-technical summary in development

Malignancies

• HIV-associated malignancies 2014

• View non-technical summary

Monitoring

• Routine investigation and monitoring of adult HIV-1-positive individuals 2016 (2019 interim update)

• Non-technical summary in development

Opportunistic infection (OI)

• Treatment of opportunistic infection in HIV-seropositive individuals 2011 *

• BHIVA guidelines on the management of opportunistic infection in people living with HIV:
  The clinical management of Candidiasis 2019

• Non-technical summary in development

• BHIVA guidelines on the management of opportunistic infection in people living with HIV:
  The clinical management of gastrointestinal opportunistic infections 2020

• View non-technical summary

PEPSE

• UK Guideline for the use of HIV Post-Exposure Prophylaxis 2021

• Non-technical summary in development

Pregnancy

• Management of HIV in pregnancy and postpartum 2018 (2020 third interim update)

• Non-technical summary in development

PrEP

• BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018 *

• Non-technical summary in development

Sexual and reproductive health

• UK guidelines for the management of sexual and reproductive health of people living with HIV infection 2008 *

• Non-technical summary in development

TB

• Management of tuberculosis in adults living with HIV 2018 (2021 interim update)

• View non-technical summary

Testing

• BHIVA/BASHH/BIA adult HIV testing guidelines 2020

• View non-technical summary

Vaccination

• Immunisation for adults with HIV: SARS-CoV-2 (COVID-19) 2021 - consultation open

• Non-technical summary in development

• Use of vaccines in HIV-positive adults 2015 *

• Non-technical summary in development

Guidelines produced by other organisations

• BVHG / BASL / BSG / BHIVA / BIA / CVN guidelines for management of chronic HCV infection 2017 (2)

• BVHG / BASL / BSG / BHIVA / BIA / CVN guidelines for management of chronic HCV infection 2017 (1)

• HIV testing: encouraging uptake - NICE quality standard [QS157] 2017

• Kidney and pancreas transplantation in patients with HIV 2015

EAGA guidance on HIV post-exposure prophylaxis (PEP)

• Updated guidance on occupational HIV post-exposure prophylaxis (PEP) from the UK Chief Medical Officers' Expert Advisory Group on AIDS (EAGA)